Exane Derivatives’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $206 | Hold |
|
|||||
|
2022
Q1 | $249 | Hold |
|
|||||
|
2021
Q4 | $454 | Hold |
|
|||||
|
2021
Q3 | $626 | Hold |
|
|||||
|
2021
Q2 | $468 | Hold |
|
|||||
|
2021
Q1 | $642 | Hold |
|
|||||
|
2020
Q4 | $652 | Hold |
|
|||||
|
2020
Q3 | $966 | Hold |
|
|||||
|
2020
Q2 | $1.21K | Hold |
|
|||||
|
2020
Q1 | $329 | Hold |
|
|||||
|
2019
Q4 | $537 | Hold |
|
|||||
|
2019
Q3 | $183 | Hold |
|
|||||
|
2019
Q2 | $486 | Hold |
|
|||||
|
2019
Q1 | $520 | Hold |
|
|||||
|
2018
Q4 | $696 | Hold |
|
|||||
|
2018
Q3 | $1.61K | Sell |
|
|||||
|
2018
Q2 | $160K | Hold |
|
|||||
|
2018
Q1 | $135K | Buy |
|